cilazapril, anhydrous has been researched along with Chronic Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knap, N; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M | 1 |
| Aleksandrowicz, E; Larczyński, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Chernov, VI; Kapishchenko, TD; Karpov, RS; Pavliukova, EN | 1 |
| Clozel, JP; Clozel, M; Hess, P; Löffler, BM; Maire, JP; Teerlink, JR | 1 |
| Bayar, MA; Erbengi, T; Iplikcioglu, AC; Sav, A | 1 |
| Brera, V; Di Michele, R; Lucini, D; Malliani, A; Pagani, M; Pizzinelli, P; Sommariva, D | 1 |
| Asakuma, S; Fujiwara, M; Iwasaki, T; Nakamura, K; Nakamura, T | 1 |
| Erbel, R; Meyer, J; Mohr-Kahaly, S; Weyer, C | 1 |
| Mulder, P; Richard, V; Thuillez, C | 1 |
| Kageyama, J; Kataoka, H; Makino, H; Ogura, T; Otsuka, F; Sato, M; Yamauchi, T | 1 |
| Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tatematsu, S; Tokuyama, H; Wakino, S | 1 |
| Clozel, JP | 1 |
4 trial(s) available for cilazapril, anhydrous and Chronic Disease
| Article | Year |
|---|---|
Spironolactone attenuates oxidative stress in patients with chronic kidney disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan | 2008 |
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Topics: Acetylglucosaminidase; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Collagen Type III; Cross-Over Studies; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Potassium; Proteinuria; Renin-Angiotensin System; Spironolactone; Telmisartan | 2008 |
[The effect of cilazapril on left ventricular function and myocardial perfusion in patients with essential hypertension (hypertensive disease) stage II].
Topics: Angina Pectoris; Antihypertensive Agents; Chronic Disease; Cilazapril; Coronary Circulation; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Single-Blind Method; Time Factors; Ventricular Function, Left | 1995 |
Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Captopril; Chronic Disease; Cilazapril; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Male; Middle Aged | 1995 |
9 other study(ies) available for cilazapril, anhydrous and Chronic Disease
| Article | Year |
|---|---|
Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
Topics: Animals; Blood Pressure; Bosentan; Chronic Disease; Cilazapril; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Male; Rats; Rats, Wistar; Sulfonamides | 1994 |
Angiotensin-converting enzyme inhibitor cilazapril prevents chronic morphologic vasospasm in rat.
Topics: Animals; Chronic Disease; Cilazapril; Disease Models, Animal; Femoral Artery; Ischemic Attack, Transient; Male; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1994 |
[The effects of chronic cilazapril treatment on sympathetic vasomotor tonus: a spectral analysis study of pressure variability].
Topics: Blood Pressure; Chronic Disease; Cilazapril; Drug Evaluation; Electrocardiography; Female; Humans; Hypertension; Male; Middle Aged; Muscle Tonus; Signal Processing, Computer-Assisted; Sympathetic Nervous System; Vasomotor System | 1993 |
[Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Chronic Disease; Cilazapril; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume | 1995 |
[Follow-up of patients with chronic aortic valve insufficiency with ACE inhibitor therapy].
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aortic Valve Insufficiency; Cardiac Volume; Chronic Disease; Cilazapril; Echocardiography; Echocardiography, Doppler, Color; Female; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Function, Left | 1997 |
Different effects of calcium antagonists in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Calcium Channel Blockers; Catecholamines; Chronic Disease; Cilazapril; Heart Failure; Heart Ventricles; Hemodynamics; Male; Mibefradil; Myocardial Contraction; Random Allocation; Rats; Rats, Wistar; Renin; Survival Rate; Tetrahydronaphthalenes | 1998 |
Chronic treatment with angiotensin II type 1 receptor antagonist suppresses glomerular activator protein-1 activity in salt-sensitive hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Nucleus; Chronic Disease; Cilazapril; Desoxycorticosterone; Electrophoresis; Heart Rate; Hypertension; Kidney Glomerulus; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Transcription Factor AP-1 | 2000 |
Differential regulation of elevated renal angiotensin II in chronic renal ischemia.
Topics: Angiotensin I; Angiotensin II; Animals; Chronic Disease; Chymases; Cilazapril; Dogs; Hemodynamics; Hypertension, Renal; Imidazoles; Ischemia; Kidney; Male; Oligopeptides; Olmesartan Medoxomil; Peptidyl-Dipeptidase A; Renal Circulation; Renin-Angiotensin System; Serine Endopeptidases; Tetrazoles | 2002 |
Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Cilazapril; Heart Failure; Hemodynamics; Myocardial Infarction; Myocardium; Pyridazines; Rats; Rats, Inbred Strains; Vascular Resistance | 1989 |